News
Brad Smith, of Arizona, has become the first person with ALS to receive a brain implant from Neuralink as part of an ongoing clinical trial.
A protein was created where TDP-43 was fused to the SUMO2 protein and these fusion proteins were expressed in cells with or ...
Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...
The Eagle-Tribune interviewed Charles “Chuck” Johnson and Nicole Johnson on April 11 for a story to show how the North ...
22h
News Medical on MSNTDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progressionReduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). Surprisingly, the protein shortage ...
Hosted on MSN16d
ALS breakthrough: Ashwagandha-derived drug shows promise in slowing progression of amyotrophic lateral sclerosisEvery year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results